{"entity":{"type":"insider","cik":"0001989401","url":"/insider/0001989401","json_url":"/insider/0001989401.json","name":"Dunn Edmund","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2024-06-05","last":"2026-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Dunn Edmund","source":"filing","n_filings":6,"first_seen":"2024-06-05","last_seen":"2026-03-05"}],"transactions":[{"id":5919339,"accession":"0001193125-26-094296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-094296","line_url":"/filing/0001193125-26-094296#line-1","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001989401","owner_name":"Dunn Edmund","owner_display_name":"Dunn Edmund","owner_url":"/insider/0001989401","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139.0,"shares_display":"139","price_per_share":17.96,"price_display":"17.96","price_state":"stated","total_value":2496.44,"total_display":"2,496.44","total_whole":"2,496","shares_owned_after":22554.0,"shares_owned_after_display":"22,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":6171531,"accession":"0001193125-26-085677","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-085677","line_url":"/filing/0001193125-26-085677#line-4","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001989401","owner_name":"Dunn Edmund","owner_display_name":"Dunn Edmund","owner_url":"/insider/0001989401","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":536.0,"shares_display":"536","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":9380.0,"total_display":"9,380.00","total_whole":"9,380","shares_owned_after":22693.0,"shares_owned_after_display":"22,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-02","scope":"insider"},{"id":6171523,"accession":"0001193125-26-085677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-085677","line_url":"/filing/0001193125-26-085677#line-2","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001989401","owner_name":"Dunn Edmund","owner_display_name":"Dunn Edmund","owner_url":"/insider/0001989401","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25164.0,"shares_display":"25,164","price_per_share":18.1015,"price_display":"18.10","price_state":"stated","total_value":455506.146,"total_display":"455,506.15","total_whole":"455,506","shares_owned_after":22693.0,"shares_owned_after_display":"22,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":5918874,"accession":"0001193125-26-002390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-002390","line_url":"/filing/0001193125-26-002390#line-1","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001989401","owner_name":"Dunn Edmund","owner_display_name":"Dunn Edmund","owner_url":"/insider/0001989401","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1039.0,"shares_display":"1,039","price_per_share":15.17,"price_display":"15.17","price_state":"stated","total_value":15761.63,"total_display":"15,761.63","total_whole":"15,762","shares_owned_after":22693.0,"shares_owned_after_display":"22,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":4062777,"accession":"0000950170-25-081637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-081637","line_url":"/filing/0000950170-25-081637#line-1","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001989401","owner_name":"Dunn Edmund","owner_display_name":"Dunn Edmund","owner_url":"/insider/0001989401","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2062.0,"shares_display":"2,062","price_per_share":4.4493,"price_display":"4.45","price_state":"stated","total_value":9174.4566,"total_display":"9,174.46","total_whole":"9,174","shares_owned_after":23732.0,"shares_owned_after_display":"23,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-04","scope":"insider"},{"id":3255193,"accession":"0000950170-24-082416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-082416","line_url":"/filing/0000950170-24-082416#line-1","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001989401","owner_name":"Dunn Edmund","owner_display_name":"Dunn Edmund","owner_url":"/insider/0001989401","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1610.0,"shares_display":"1,610","price_per_share":3.8301,"price_display":"3.83","price_state":"stated","total_value":6166.461,"total_display":"6,166.46","total_whole":"6,166","shares_owned_after":13944.0,"shares_owned_after_display":"13,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-09","scope":"insider"},{"id":3152254,"accession":"0000950170-24-069310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-069310","line_url":"/filing/0000950170-24-069310#line-1","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001989401","owner_name":"Dunn Edmund","owner_display_name":"Dunn Edmund","owner_url":"/insider/0001989401","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1207.0,"shares_display":"1,207","price_per_share":4.0396,"price_display":"4.04","price_state":"stated","total_value":4875.7972,"total_display":"4,875.80","total_whole":"4,876","shares_owned_after":15554.0,"shares_owned_after_display":"15,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Officer (Principal Accounting Officer)","n_filings":6,"first_seen":"2024-06-05","last_seen":"2026-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001989401","retrieved_at":"2026-08-24T09:21:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}